Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Sato Pharmaceutical patents new HPGDS inhibitors

Jan. 11, 2022

Autobahn Therapeutics discloses thyroid hormone receptor agonists

Jan. 11, 2022

Volastra Therapeutics identifies ENPP1 inhibitors

Jan. 10, 2022

Incyte synthesizes new JAK2 V617F inhibitors

Jan. 10, 2022

Gossamer Bio presents DGKA and/or DGKZ inhibitors

Jan. 10, 2022

The Vanderbilt University divulges new muscarinic M5 receptor antagonists

Jan. 10, 2022

Dana-Farber Cancer Institute patents UCP1 activators

Jan. 10, 2022

Wigen Biomedicine Technology synthesizes new Wee1 inhibitors

Jan. 7, 2022

Chinese researchers describe new GLP-1 receptor agonists

Jan. 7, 2022

Anaxis Pharma identifies new RIPK1 and/or MLKL inhibitors

Jan. 7, 2022

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...